Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| UNITAID | OTHER |
Not provided
Not provided
Not provided
Not provided
This study aims to assess the feasibility and utility of birth testing using point-of-care (POC) testing in maternity settings in Eswatini.
This UNITAID-funded study aims to assess feasibility and utility of birth testing, [early infant diagnosis for HIV, (EID)], using point-of-care (POC) HIV nucleic acid testing (NAT) at high volume maternity settings. Birth testing is defined as tests within 3 days of life. Outcome measures will include age at testing, turnaround time from testing to caregiver result receipt, HIV positivity rate, and timing of anti-retroviral therapy (ART) initiation for HIV-positive infants. The study will document retention in care for those who tested positive at birth, and the percent of those who tested negative at birth who returned for six week testing. The study will also assess the feasibility and acceptability of POC birth testing using interviews with policymakers, health care workers and caregivers of HIV-exposed infants (HEI).
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| HIV-exposed infants (HEI) eligible for birth testing | All HEI live births born at, or presenting to, one of the 3 study sites, within 3 days of birth. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Point-of-care birth test | Diagnostic Test | Collect quantitative data through clinical chart and form abstractions; collect qualitative data through in-depth interviews with caregivers, health workers and policymakers |
| Measure | Description | Time Frame |
|---|---|---|
| Percent of eligible HEI born at or presenting to pilot facilities who receive POC EID testing at birth | Number of eligible HEI born at or presenting to pilot facilities receiving POC EID testing as a proportion of the number of HEI born or presenting to pilot facilities | 24 months |
| Measure | Description | Time Frame |
|---|---|---|
| Percent of tested HEI whose caregivers receive results of the POC EID birth testing | Number of tested HEI whose caregivers receive results of the POC EID birth testing as a proportion of the number of tested HEI | 24 months |
| HIV positivity rate among HEI tested at birth |
Not provided
Inclusion Criteria:
HIV Exposed Infants
Health Care Workers (HCWs)
Laboratory Managers and program leads/focal persons:
Mothers/caregivers:
Exclusion Criteria:
HEIs:
HCWs:
Laboratory Managers and program leads/focal persons:
Mothers/Caregivers:
Not provided
Not provided
Not provided
Not provided
For quantitative component:
All HEIs newly born at the selected sites or presenting in study sites within 3 days after birth
For qualitative component:
Health care workers and phlebotomists who are currently employed in study sites who are involved in providing POC EID services
Laboratory managers and program leads/focal persons at the Ministry of Health
Mothers/caregivers of HEI delivered or presenting in study sites within 3 days after birthwho were offered POC HIV EID testing at birth
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Jennifer Cohn | Elizabeth Glaser Pediatric AIDS Foundation | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Mbabane Government Hospital, Hlathikhulu Hospital, and Good Shepherd Hospital | Mbabane | Eswatini |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D015658 | HIV Infections |
| D000163 | Acquired Immunodeficiency Syndrome |
| ID | Term |
|---|---|
| D000086982 | Blood-Borne Infections |
| D003141 | Communicable Diseases |
| D007239 | Infections |
| D015229 | Sexually Transmitted Diseases, Viral |
Not provided
Not provided
Not provided
Not provided
Not provided
Number of HEI testing HIV positive at birth as a proportion of the number of HEI tested at birth |
| 24 months |
| Number of HIV-infected infants (HII) tested at birth who are started on ART within 2 weeks of the birth test | Number of HII tested at birth started on ART within 2 weeks as a proportion of the number of HII tested at birth | 24 months |
| Percent of HEI testing HIV negative at birth who return for testing at 6-8 weeks | Number of HEI testing HIV negative at birth who return for testing at 6-8 weeks as a proportion of the number of HEI testing HIV negative at birth | 24 months |
| Percent of HEI who test HIV negative at birth and who test positive at 6-8 weeks | Number of HEI who test HIV negative at birth and who test HIV positive at 6-8 weeks as a proportion of the number of HEI who test HIV negative at birth | 24 months |
| Percent of HII testing HIV positive at birth or at 6-8 weeks in care for the first 3 and/or 6 months of life | The number of HII testing HIV positive at birth or at 6-8 weeks in care for the first and/or 6 months of life as a proportion of the number of HII testing HIV positive at birth or at 6-8 week of life | 24 months |
| D012749 | Sexually Transmitted Diseases |
| D016180 | Lentivirus Infections |
| D012192 | Retroviridae Infections |
| D012327 | RNA Virus Infections |
| D014777 | Virus Diseases |
| D000091662 | Genital Diseases |
| D000091642 | Urogenital Diseases |
| D007153 | Immunologic Deficiency Syndromes |
| D007154 | Immune System Diseases |
| D012897 | Slow Virus Diseases |